AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

65 hedge funds and large institutions have $30.9M invested in Akebia Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.

Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
15
Reduced
15
Closed
16
Calls
$466K
Puts
$81K
Net Calls
+$385K
Net Calls Change
+$24K

Top Buyers

1
MFS
1
Mirabella Financial Services
United Kingdom
$1.83M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.01M
3
AIM
3
Alerce Investment Management
Illinois
$9.08M
4
Morgan Stanley
4
Morgan Stanley
New York
$361K
5
Victory Capital Management
5
Victory Capital Management
Texas
$144K

Top Sellers

1
OCM
1
Ovata Capital Management
Hong Kong
$0
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$672K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.31M
4
Jane Street
4
Jane Street
New York
$25.9K
5
Millennium Management
5
Millennium Management
New York
$511K
Name Market Value Shares Shares
Change 		Shares
Change %
USCWA
76
U.S. Capital Wealth Advisors
Texas
– – -1,871 Closed
EWA
77
EverSource Wealth Advisors
Alabama
– – -1,250 Closed
Northwestern Mutual Wealth Management
78
Northwestern Mutual Wealth Management
Wisconsin
– – -374 Closed
Belvedere Trading
79
Belvedere Trading
Illinois
– – -100 Closed
CS
80
Credit Suisse
Switzerland
– – -5 Closed
Simplex Trading
81
Simplex Trading
Illinois
– – – –
CAL
82
Capital Advisors Ltd
Ohio
$0 320 – –
Wolverine Trading
83
Wolverine Trading
Illinois
– – – –
CFGS
84
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4